Full article
How does a brief get approved by everyone, then start coming apart as soon as production is booked? In UK healthcare launch governance, the break usually happens after sign-off and before delivery. Ownership is assumed, not assigned. Dates drift. A dependency everyone thought was closed turns out to be open after all.
The short answer: MAIA matters before creative production because it turns an approved brief into a governed route with named owners, dated checkpoints, acceptance criteria and attached evidence. The comparison that matters is not strategy versus execution. It is governed campaign planning versus the informal handoff spread across inboxes, chat threads and collective memory.
This decision brief looks at those two options before creative starts: the handoff teams often tolerate, and a MAIA workflow built to show whether anything important can still slip between approval, production and measurement.
What is being decided
The question is not whether the brief has been approved. It is whether the campaign is genuinely ready for production.
That is a harder standard. A brief can be signed off and still leave basic operational questions hanging: who clears the next gate, when a dependency must be resolved, what evidence counts as complete, and what happens if that evidence is missing at handoff. If those points are not written down, the route is not settled.
A practical approval map for launch governance usually needs four things visible before creative starts: a named owner for each approval, a date for each dependency, acceptance criteria for the handoff, and the risk if any of them stay open. If your plan has no named owners and dates, it is not a plan, fix it.
Comparative view
Most teams do not set out to create an informal handoff. They inherit one. A run of emails, a chat thread, a broad approval, then production is asked to get moving because time is a bit tight. That arrangement holds until claims wording, legal text or medical review is revealed not to be final.
The governed alternative is less forgiving and much easier to inspect. MAIA turns the handoff into a controlled checkpoint with visible ownership, route status and supporting evidence. The difference is easiest to see on one launch-critical task: approval of promotional claims.
| Checkpoint | Informal handoff | Governed workflow in MAIA |
|---|---|---|
| Owner | Implied through CC lists or whoever replied last. | Named approver assigned to the task, with a visible owner and status. |
| Date | Loose request such as “end of week”. | Fixed due date tracked in the workflow, with alerts if it slips. |
| Acceptance criteria | Unclear. “Approved” may refer to the wrong version. | Specific evidence required before the gate clears, such as the final substantiation pack and approved claim wording. |
| Audit trail | Spread across inboxes and chat history. | Single record of decision, version, owner, and timestamp. |
| Consequence of delay | Usually discovered by production after the fact. | Visible upstream as a blocked route with an identified risk and mitigation. |
That is where campaign planning automation earns its place. Not by putting a tidy interface over poor decisions. By making decision points harder to miss, and easier to prove.
Where the operational risk actually lands
The weak point is rarely the brief itself. It is the handoff from approval into production. Once work starts, unresolved dependencies stop looking like planning gaps and start showing up as wasted spend, delayed delivery and compliance exposure.
That creates three operational problems fast:
- Spend starts leaking: if design, copy or studio time is booked before dependencies are green, paid resource sits idle. One unresolved approval can stall a shoot, an edit slot or an agency booking.
- Compliance risk moves downstream: if assets are built from draft claims or unapproved references, they need rework or withdrawal. The cost is not just the remake. It is the chance of the wrong version travelling further than it should.
- Decision quality drops under pressure: once production is under way, teams are more likely to accept weak workarounds to protect dates. That is exactly the point where governance needs to hold.
There is no need to force a spurious annualised cost onto that drag. The more useful signs are operational and visible: blocked tickets, slipped production dates, duplicate reviews, and acceptance criteria rewritten after work has already started.
What campaign teams need to stay aligned
A usable approval map for UK healthcare launch governance needs to be short enough to run and strict enough to stop avoidable churn. Before creative production, teams usually need at least these checkpoints defined in one route:
- Claims and medical review: named owner, evidence attached, final wording version identified.
- Legal and compliance check: due date agreed, approval route explicit, rejection criteria known in advance.
- Brand and channel readiness: templates, mandatory copy, audience constraints and format limits confirmed.
- Production handoff: one accepted pack containing the approved brief, asset list, dependencies and route status.
Each checkpoint needs a measurable test. For example: owner assigned, due date set, latest approved version attached, and no open critical dependency at handoff. If one of those is missing, the route is not green. Call it amber, then resolve it before the studio burns time on rework that was entirely predictable.
This is also where the change log stops being admin and starts doing its real job. If dates move, owners change or evidence is replaced, the record should show what changed and why. Without that traceability, delay turns into folklore and no one can say with confidence which version was actually cleared.
Where MAIA fits best
The stronger option is the governed workflow. Not because process is inherently virtuous. It is not. It is stronger because healthcare launches carry too much approval risk to rely on inbox archaeology and memory.
MAIA fits best where teams need a campaign operating model that makes ownership, sequencing and proof visible before work fans out. It gives delivery leads a clearer route into production: named owners, tracked dates, explicit acceptance criteria, visible risks and a cleaner handoff into execution. The proof links are straightforward if you want to see how MAIA is positioned in that role: MAIA and Holograph solutions.
Holograph matters here as the implementation owner when the workflow needs to match your actual approval path rather than a generic template. In healthcare, that matters. The route is rarely neat, and the awkward dependency is usually the one that causes the trouble later.
Recommendation and next step
If the decision is between brief-by-brief coordination and a governed handoff, choose the governed route. The real test is plain enough: can anything important still slip quietly between strategy, production and measurement? If the answer is yes, the brief may be approved, but the launch is not ready.
The next step is modest. Map your current pre-production approvals, assign the owner and due date for each one, and mark where evidence is assumed rather than attached. That exercise usually shows the weak point quickly. If you want help turning that into a MAIA workflow with a credible path to green, get in touch. We can review the approval map, pressure-test the risks, and help settle the checkpoints before creative production starts.
